UNICHEM LABORATORIES LTD.

Company Profile

UNICHEM LABORATORIES LTD. had its IPO on under the ticker symbol UNICHEMLAB.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. UNICHEM LABORATORIES LTD. has a staff strength of 3,167 employees.

Stock update

Shares of UNICHEM LABORATORIES LTD. opened at ₹433.3 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹400.9 - ₹433.3, and closed at ₹405.25.

This is a -5.59% slip from the previous day's closing price.

A total volume of 11,658 shares were traded at the close of the day’s session.

In the last one week, shares of UNICHEM LABORATORIES LTD. have slipped by -3%.

UNICHEM LABORATORIES LTD.'s Key Ratios

UNICHEM LABORATORIES LTD. has a market cap of ₹23.36 billion, indicating a price to book ratio of 0.9328 and a price to sales ratio of 1.732.

In the last 12-months UNICHEM LABORATORIES LTD.’s revenue was ₹13.11 billion with a gross profit of ₹8.01 billion and an EBITDA of ₹-52158500. The EBITDA ratio measures UNICHEM LABORATORIES LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, UNICHEM LABORATORIES LTD.’s operating margin was -7.44% while its return on assets stood at -0.87% with a return of equity of -1.45%.

In Q4, UNICHEM LABORATORIES LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a negative 2.8%.

UNICHEM LABORATORIES LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹-12.31 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into UNICHEM LABORATORIES LTD.’s profitability.

UNICHEM LABORATORIES LTD. stock is trading at a EV to sales ratio of 1.8017 and a EV to EBITDA ratio of 26.6364. Its price to sales ratio in the trailing 12-months stood at 1.732.

UNICHEM LABORATORIES LTD. stock pays annual dividends of ₹0 per share, indicating a yield of 1.38% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹0

Total Liabilities

₹0

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

UNICHEM LABORATORIES LTD. ended 2025 with ₹0 in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹0 while shareholder equity stood at ₹0.

UNICHEM LABORATORIES LTD. ended 2025 with ₹0 in deferred long-term liabilities, ₹0 in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

UNICHEM LABORATORIES LTD.’s total current assets stands at ₹0 while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹0 compared to accounts payable of ₹0 and inventory worth ₹0.

In 2025, UNICHEM LABORATORIES LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, UNICHEM LABORATORIES LTD. paid ₹0 in dividends in 2025.

Other key metrics

Current Trading Price

₹405.25

52-Week High

₹466.95

52-Week Low

₹223.7909

Analyst Target Price

₹

UNICHEM LABORATORIES LTD. stock is currently trading at ₹405.25 per share. It touched a 52-week high of ₹466.95 and a 52-week low of ₹466.95. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹399.49 and 200-day moving average was ₹352.68 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 5288.2% of the company’s stock are held by insiders while 824.1% are held by institutions.